{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T17:55:31Z","timestamp":1788630931846,"version":"build-2803163510"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T00:00:00Z","timestamp":1520294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T00:00:00Z","timestamp":1520294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH095671"],"award-info":[{"award-number":["R01MH095671"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH104134"],"award-info":[{"award-number":["R01MH104134"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH101017"],"award-info":[{"award-number":["R01MH101017"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["F30MH102120"],"award-info":[{"award-number":["F30MH102120"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["T32NS007180"],"award-info":[{"award-number":["T32NS007180"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12974-018-1102-z","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T11:17:42Z","timestamp":1520335062000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Heme oxygenase-1 promoter region (GT)n polymorphism associates with increased neuroimmune activation and risk for encephalitis in HIV infection"],"prefix":"10.1186","volume":"15","author":[{"given":"Alexander J.","family":"Gill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando","family":"Garza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surendra S.","family":"Ambegaokar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin B.","family":"Gelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis L.","family":"Kolson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,6]]},"reference":[{"key":"1102_CR1","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev.pharmtox.010909.105600","volume":"50","author":"R Gozzelino","year":"2010","unstructured":"Gozzelino R, Jeney V, Soares MP. Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol. 2010;50:323\u201354.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1102_CR2","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.1172\/JCI72279","volume":"124","author":"AJ Gill","year":"2014","unstructured":"Gill AJ, Kovacsics CE, Cross SA, Vance PJ, Kolson LL, Jordan-Sciutto KL, Gelman BB, Kolson DL. Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disorders. J Clin Invest. 2014;124:4459\u201372.","journal-title":"J Clin Invest"},{"key":"1102_CR3","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/glia.23160","volume":"65","author":"CE Kovacsics","year":"2017","unstructured":"Kovacsics CE, Gill AJ, Ambegaokar SS, Gelman BB, Kolson DL. Degradation of heme oxygenase-1 by the immunoproteasome in astrocytes: a potential interferon-gamma-dependent mechanism contributing to HIV neuropathogenesis. Glia. 2017;65:1264\u201377.","journal-title":"Glia"},{"key":"1102_CR4","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.4049\/jimmunol.1101868","volume":"187","author":"SA Cross","year":"2011","unstructured":"Cross SA, Cook DR, Chi AW, Vance PJ, Kolson LL, Wong BJ, Jordan-Sciutto KL, Kolson DL. Dimethyl fumarate, an immune modulator and inducer of the antioxidant response, suppresses HIV replication and macrophage-mediated neurotoxicity: a novel candidate for HIV neuroprotection. J Immunol. 2011;187:5015\u201325.","journal-title":"J Immunol"},{"key":"1102_CR5","doi-asserted-by":"publisher","first-page":"10656","DOI":"10.1128\/JVI.01495-15","volume":"89","author":"AJ Gill","year":"2015","unstructured":"Gill AJ, Kovacsics CE, Vance PJ, Collman RG, Kolson DL. Induction of heme oxygenase-1 deficiency and associated glutamate-mediated neurotoxicity is a highly conserved HIV phenotype of chronic macrophage infection that is resistant to antiretroviral therapy. J Virol. 2015;89:10656\u201367.","journal-title":"J Virol"},{"key":"1102_CR6","doi-asserted-by":"publisher","first-page":"e77224","DOI":"10.1371\/journal.pone.0077224","volume":"8","author":"M Kramer","year":"2013","unstructured":"Kramer M, Sponholz C, Slaba M, Wissuwa B, Claus RA, Menzel U, Huse K, Platzer M, Bauer M. Alternative 5\u2032 untranslated regions are involved in expression regulation of human heme oxygenase-1. PLoS One. 2013;8:e77224.","journal-title":"PLoS One"},{"key":"1102_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1086\/302729","volume":"66","author":"N Yamada","year":"2000","unstructured":"Yamada N, Yamaya M, Okinaga S, Nakayama K, Sekizawa K, Shibahara S, Sasaki H. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet. 2000;66:187\u201395.","journal-title":"Am J Hum Genet"},{"key":"1102_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00439-002-0769-4","volume":"111","author":"YH Chen","year":"2002","unstructured":"Chen YH, Lin SJ, Lin MW, Tsai HL, Kuo SS, Chen JW, Charng MJ, Wu TC, Chen LC. Ding YA, et al: microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet. 2002;111:1\u20138.","journal-title":"Hum Genet"},{"key":"1102_CR9","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1097\/01.TP.0000113467.36269.F8","volume":"77","author":"M Exner","year":"2004","unstructured":"Exner M, Bohmig GA, Schillinger M, Regele H, Watschinger B, Horl WH, Raith M, Mannhalter C, Wagner OF. Donor heme oxygenase-1 genotype is associated with renal allograft function. Transplantation. 2004;77:538\u201342.","journal-title":"Transplantation"},{"key":"1102_CR10","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1097\/00004872-200308000-00013","volume":"21","author":"K Ono","year":"2003","unstructured":"Ono K, Mannami T, Iwai N. Association of a promoter variant of the haeme oxygenase-1 gene with hypertension in women. J Hypertens. 2003;21:1497\u2013503.","journal-title":"J Hypertens"},{"key":"1102_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.atherosclerosis.2003.11.021","volume":"173","author":"K Ono","year":"2004","unstructured":"Ono K, Goto Y, Takagi S, Baba S, Tago N, Nonogi H, Iwai N. A promoter variant of the heme oxygenase-1 gene may reduce the incidence of ischemic heart disease in Japanese. Atherosclerosis. 2004;173:315\u20139.","journal-title":"Atherosclerosis"},{"key":"1102_CR12","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1182\/blood-2002-12-3733","volume":"102","author":"H Hirai","year":"2003","unstructured":"Hirai H, Kubo H, Yamaya M, Nakayama K, Numasaki M, Kobayashi S, Suzuki S, Shibahara S, Sasaki H. Microsatellite polymorphism in heme oxygenase-1 gene promoter is associated with susceptibility to oxidant-induced apoptosis in lymphoblastoid cell lines. Blood. 2003;102:1619\u201321.","journal-title":"Blood"},{"key":"1102_CR13","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/gene.2011.76","volume":"13","author":"L Seu","year":"2012","unstructured":"Seu L, Burt TD, Witte JS, Martin JN, Deeks SG, McCune JM. Variations in the heme oxygenase-1 microsatellite polymorphism are associated with plasma CD14 and viral load in HIV-infected African-Americans. Genes Immun. 2012;13:258\u201367.","journal-title":"Genes Immun"},{"key":"1102_CR14","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.1002\/art.23048","volume":"56","author":"B Rueda","year":"2007","unstructured":"Rueda B, Oliver J, Robledo G, Lopez-Nevot MA, Balsa A, Pascual-Salcedo D, Gonzalez-Gay MA, Gonzalez-Escribano MF, Martin J. HO-1 promoter polymorphism associated with rheumatoid arthritis. Arthritis Rheum. 2007;56:3953\u20138.","journal-title":"Arthritis Rheum"},{"key":"1102_CR15","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s12192-011-0309-z","volume":"17","author":"M Chen","year":"2012","unstructured":"Chen M, Zhou L, Ding H, Huang S, He M, Zhang X, Cheng L, Wang D, Hu FB, Wu T. Short (GT) ( n ) repeats in heme oxygenase-1 gene promoter are associated with lower risk of coronary heart disease in subjects with high levels of oxidative stress. Cell Stress Chaperones. 2012;17:329\u201338.","journal-title":"Cell Stress Chaperones"},{"key":"1102_CR16","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1097\/MPA.0000000000000171","volume":"43","author":"A Gulla","year":"2014","unstructured":"Gulla A, Evans BJ, Navenot JM, Pundzius J, Barauskas G, Gulbinas A, Dambrauskas Z, Arafat H, Wang ZX. Heme oxygenase-1 gene promoter polymorphism is associated with the development of necrotizing acute pancreatitis. Pancreas. 2014;43:1271\u20136.","journal-title":"Pancreas"},{"key":"1102_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1620\/tjem.231.201","volume":"231","author":"G Vazquez-Armenta","year":"2013","unstructured":"Vazquez-Armenta G, Gonzalez-Leal N, JV-dlT M, Munoz-Valle JF, Ramos-Marquez ME, Hernandez-Canaveral I, Plascencia-Hernandez A, Siller-Lopez F. Short (GT)n microsatellite repeats in the heme oxygenase-1 gene promoter are associated with antioxidant and anti-inflammatory status in Mexican pediatric patients with sepsis. Tohoku J Exp Med. 2013;231:201\u20139.","journal-title":"Tohoku J Exp Med"},{"key":"1102_CR18","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1136\/jmg.2005.035824","volume":"43","author":"H Yasuda","year":"2006","unstructured":"Yasuda H, Okinaga S, Yamaya M, Ohrui T, Higuchi M, Shinkawa M, Itabashi S, Nakayama K, Asada M, Kikuchi A, et al. Association of susceptibility to the development of pneumonia in the older Japanese population with haem oxygenase-1 gene promoter polymorphism. J Med Genet. 2006;43:e17.","journal-title":"J Med Genet"},{"key":"1102_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1423-0127-17-12","volume":"17","author":"CH Bai","year":"2010","unstructured":"Bai CH, Chen JR, Chiu HC, Chou CC, Chau LY, Pan WH. Shorter GT repeat polymorphism in the heme oxygenase-1 gene promoter has protective effect on ischemic stroke in dyslipidemia patients. J Biomed Sci. 2010;17:12.","journal-title":"J Biomed Sci"},{"key":"1102_CR20","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1046\/j.0305-1846.2001.00334.x","volume":"27","author":"S Morgello","year":"2001","unstructured":"Morgello S, Gelman BB, Kozlowski PB, Vinters HV, Masliah E, Cornford M, Cavert W, Marra C, Grant I, Singer EJ. The National NeuroAIDS Tissue Consortium: a new paradigm in brain banking with an emphasis on infectious disease. Neuropathol Appl Neurobiol. 2001;27:326\u201335.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1102_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11481-016-9652-2","volume":"11","author":"T Buzhdygan","year":"2016","unstructured":"Buzhdygan T, Lisinicchia J, Patel V, Johnson K, Neugebauer V, Paessler S, Jennings K, Gelman B. Neuropsychological, neurovirological and neuroimmune aspects of abnormal GABAergic transmission in HIV infection. J NeuroImmune Pharmacol. 2016;11:279\u201393.","journal-title":"J NeuroImmune Pharmacol"},{"key":"1102_CR22","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s11481-012-9345-4","volume":"7","author":"BB Gelman","year":"2012","unstructured":"Gelman BB, Lisinicchia JG, Chen T, Johnson KM, Jennings K, Freeman DH Jr, Soukup VM. Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis. J NeuroImmune Pharmacol. 2012;7:686\u2013700.","journal-title":"J NeuroImmune Pharmacol"},{"key":"1102_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1750-3639.1991.tb00653.x","volume":"1","author":"H Budka","year":"1991","unstructured":"Budka H, Wiley CA, Kleihues P, Artigas J, Asbury AK, Cho ES, Cornblath DR, Dal Canto MC, DeGirolami U, Dickson D, et al. HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol. 1991;1:143\u201352.","journal-title":"Brain Pathol"},{"key":"1102_CR24","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/QAI.0b013e31827f1bdb","volume":"62","author":"BB Gelman","year":"2013","unstructured":"Gelman BB, Lisinicchia JG, Morgello S, Masliah E, Commins D, Achim CL, Fox HS, Kolson DL, Grant I, Singer E, et al. Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort. J Acquir Immune Defic Syndr. 2013;62:487\u201395.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1102_CR25","doi-asserted-by":"publisher","first-page":"893","DOI":"10.2353\/ajpath.2010.090390","volume":"176","author":"TP Nguyen","year":"2010","unstructured":"Nguyen TP, Soukup VM, Gelman BB. Persistent hijacking of brain proteasomes in HIV-associated dementia. Am J Pathol. 2010;176:893\u2013902.","journal-title":"Am J Pathol"},{"key":"1102_CR26","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jns.2014.06.046","volume":"344","author":"L Cao","year":"2014","unstructured":"Cao L, Zhang Z, Cai B, Bai W, Zhang Y, Sun W, Xie X, Sun W, Cai Q, Li Z, et al. Association of heme oxygenase-1 gene rs2071746 polymorphism with vascular outcomes in patients with atherosclerotic stroke. J Neurol Sci. 2014;344:154\u20137.","journal-title":"J Neurol Sci"},{"key":"1102_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/SHK.0b013e31826ae951","volume":"38","author":"C Sponholz","year":"2012","unstructured":"Sponholz C, Huse K, Kramer M, Giamarellos-Bourboulis EJ, Claus RA, Kern A, Engel C, Kuhnt E, Kiehntopf M, Routsi C, et al. Gene polymorphisms in the heme degradation pathway and outcome of severe human sepsis. Shock. 2012;38:459\u201365.","journal-title":"Shock"},{"key":"1102_CR28","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000161059","volume":"26","author":"I Mateo","year":"2008","unstructured":"Mateo I, Sanchez-Juan P, Rodriguez-Rodriguez E, Infante J, Vazquez-Higuera JL, Garcia-Gorostiaga I, Berciano J, Combarros O. Synergistic effect of heme oxygenase-1 and tau genetic variants on Alzheimer\u2019s disease risk. Dement Geriatr Cogn Disord. 2008;26:339\u201342.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1102_CR29","doi-asserted-by":"publisher","first-page":"4252","DOI":"10.4049\/jimmunol.176.7.4252","volume":"176","author":"K Devadas","year":"2006","unstructured":"Devadas K, Dhawan S. Hemin activation ameliorates HIV-1 infection via heme oxygenase-1 induction. J Immunol. 2006;176:4252\u20137.","journal-title":"J Immunol"},{"key":"1102_CR30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nrneurol.2016.53","volume":"12","author":"D Saylor","year":"2016","unstructured":"Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, Mankowski JL, Brown A, Volsky DJ, McArthur JC. HIV-associated neurocognitive disorder\u2014pathogenesis and prospects for treatment. Nat Rev Neurol. 2016;12:309.","journal-title":"Nat Rev Neurol"},{"key":"1102_CR31","first-page":"3","volume":"17","author":"RK Heaton","year":"2011","unstructured":"Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neuro-Oncol. 2011;17:3\u201316.","journal-title":"J Neuro-Oncol"},{"key":"1102_CR32","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/QAD.0000000000000545","volume":"29","author":"NI Wada","year":"2015","unstructured":"Wada NI, Jacobson LP, Margolick JB, Breen EC, Macatangay B, Penugonda S, Martinez-Maza O, Bream JH. The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation. AIDS. 2015;29:463\u201371.","journal-title":"AIDS"},{"key":"1102_CR33","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/cid\/ciw683","volume":"64","author":"I Sereti","year":"2017","unstructured":"Sereti I, Krebs SJ, Phanuphak N, Fletcher JL, Slike B, Pinyakorn S, O'Connell RJ, Rupert A, Chomont N, Valcour V, et al. Persistent, albeit reduced, chronic inflammation in persons starting antiretroviral therapy in acute HIV infection. Clin Infect Dis. 2017;64:124\u201331.","journal-title":"Clin Infect Dis"},{"key":"1102_CR34","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/COH.0000000000000019","volume":"9","author":"NT Funderburg","year":"2014","unstructured":"Funderburg NT. Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients. Curr Opin HIV AIDS. 2014;9:80\u20136.","journal-title":"Curr Opin HIV AIDS"},{"key":"1102_CR35","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.mehy.2009.12.010","volume":"74","author":"D Garcia-Santos","year":"2010","unstructured":"Garcia-Santos D, Chies JA. HO-1 polymorphism as a genetic determinant behind the malaria resistance afforded by haemolytic disorders. Med Hypotheses. 2010;74:807\u201313.","journal-title":"Med Hypotheses"},{"key":"1102_CR36","doi-asserted-by":"publisher","first-page":"e1002579","DOI":"10.1371\/journal.ppat.1002579","volume":"8","author":"M Walther","year":"2012","unstructured":"Walther M, De Caul A, Aka P, Njie M, Amambua-Ngwa A, Walther B, Predazzi IM, Cunnington A, Deininger S, Takem EN, et al. HMOX1 gene promoter alleles and high HO-1 levels are associated with severe malaria in Gambian children. PLoS Pathog. 2012;8:e1002579.","journal-title":"PLoS Pathog"},{"key":"1102_CR37","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1182\/blood-2011-06-361642","volume":"120","author":"CJ Bean","year":"2012","unstructured":"Bean CJ, Boulet SL, Ellingsen D, Pyle ME, Barron-Casella EA, Casella JF, Payne AB, Driggers J, Trau HA, Yang G, et al. Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease. Blood. 2012;120:3822\u20138.","journal-title":"Blood"},{"key":"1102_CR38","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1161\/01.RES.85.8.663","volume":"85","author":"S Hayashi","year":"1999","unstructured":"Hayashi S, Takamiya R, Yamaguchi T, Matsumoto K, Tojo SJ, Tamatani T, Kitajima M, Makino N, Ishimura Y, Suematsu M. Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. Circ Res. 1999;85:663\u201371.","journal-title":"Circ Res"},{"key":"1102_CR39","doi-asserted-by":"publisher","first-page":"10919","DOI":"10.1073\/pnas.94.20.10919","volume":"94","author":"KD Poss","year":"1997","unstructured":"Poss KD, Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci U S A. 1997;94:10919\u201324.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1102_CR40","doi-asserted-by":"publisher","first-page":"10925","DOI":"10.1073\/pnas.94.20.10925","volume":"94","author":"KD Poss","year":"1997","unstructured":"Poss KD, Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci U S A. 1997;94:10925\u201330.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1102_CR41","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1161\/HYPERTENSIONAHA.107.092296","volume":"50","author":"SR Datla","year":"2007","unstructured":"Datla SR, Dusting GJ, Mori TA, Taylor CJ, Croft KD, Jiang F. Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress. Hypertension. 2007;50:636\u201342.","journal-title":"Hypertension"},{"key":"1102_CR42","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/jnr.20681","volume":"82","author":"J Chen-Roetling","year":"2005","unstructured":"Chen-Roetling J, Benvenisti-Zarom L, Regan RF. Cultured astrocytes from heme oxygenase-1 knockout mice are more vulnerable to heme-mediated oxidative injury. J Neurosci Res. 2005;82:802\u201310.","journal-title":"J Neurosci Res"},{"key":"1102_CR43","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.nbd.2004.07.009","volume":"17","author":"ZP Teng","year":"2004","unstructured":"Teng ZP, Chen J, Chau LY, Galunic N, Regan RF. Adenoviral transfer of the heme oxygenase-1 gene protects striatal astrocytes from heme-mediated oxidative injury. Neurobiol Dis. 2004;17:179\u201387.","journal-title":"Neurobiol Dis"},{"key":"1102_CR44","doi-asserted-by":"publisher","first-page":"e64372","DOI":"10.1371\/journal.pone.0064372","volume":"8","author":"A Quincozes-Santos","year":"2013","unstructured":"Quincozes-Santos A, Bobermin LD, Latini A, Wajner M, Souza DO, Goncalves CA, Gottfried C. Resveratrol protects C6 astrocyte cell line against hydrogen peroxide-induced oxidative stress through heme oxygenase 1. PLoS One. 2013;8:e64372.","journal-title":"PLoS One"},{"key":"1102_CR45","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1124\/mol.108.048611","volume":"74","author":"SY Hung","year":"2008","unstructured":"Hung SY, Liou HC, Kang KH, Wu RM, Wen CC, Fu WM. Overexpression of heme oxygenase-1 protects dopaminergic neurons against 1-methyl-4-phenylpyridinium-induced neurotoxicity. Mol Pharmacol. 2008;74:1564\u201375.","journal-title":"Mol Pharmacol"},{"key":"1102_CR46","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1046\/j.1471-4159.2000.0750304.x","volume":"75","author":"K Chen","year":"2000","unstructured":"Chen K, Gunter K, Maines MD. Neurons overexpressing heme oxygenase-1 resist oxidative stress-mediated cell death. J Neurochem. 2000;75:304\u201313.","journal-title":"J Neurochem"},{"key":"1102_CR47","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1073\/pnas.91.7.2607","volume":"91","author":"GF Vile","year":"1994","unstructured":"Vile GF, Basu-Modak S, Waltner C, Tyrrell RM. Heme oxygenase 1 mediates an adaptive response to oxidative stress in human skin fibroblasts. Proc Natl Acad Sci U S A. 1994;91:2607\u201310.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1102_CR48","doi-asserted-by":"crossref","first-page":"18148","DOI":"10.1016\/S0021-9258(19)37165-0","volume":"267","author":"G Balla","year":"1992","unstructured":"Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, Eaton JW, Vercellotti GM. Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem. 1992;267:18148\u201353.","journal-title":"J Biol Chem"},{"key":"1102_CR49","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.lfs.2012.05.019","volume":"90","author":"N Bhaskaran","year":"2012","unstructured":"Bhaskaran N, Shukla S, Kanwal R, Srivastava JK, Gupta S. Induction of heme oxygenase-1 by chamomile protects murine macrophages against oxidative stress. Life Sci. 2012;90:1027\u201333.","journal-title":"Life Sci"},{"key":"1102_CR50","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1038\/jid.2011.56","volume":"131","author":"Z Jian","year":"2011","unstructured":"Jian Z, Li K, Liu L, Zhang Y, Zhou Z, Li C, Gao T. Heme oxygenase-1 protects human melanocytes from H2O2-induced oxidative stress via the Nrf2-ARE pathway. J Invest Dermatol. 2011;131:1420\u20137.","journal-title":"J Invest Dermatol"},{"key":"1102_CR51","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S0002-9440(10)63365-2","volume":"165","author":"MH Kapturczak","year":"2004","unstructured":"Kapturczak MH, Wasserfall C, Brusko T, Campbell-Thompson M, Ellis TM, Atkinson MA, Agarwal A. Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Am J Pathol. 2004;165:1045\u201353.","journal-title":"Am J Pathol"},{"key":"1102_CR52","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1442-200X.2007.02353.x","volume":"49","author":"S Koizumi","year":"2007","unstructured":"Koizumi S. Human heme oxygenase-1 deficiency: a lesson on serendipity in the discovery of the novel disease. Pediatr Int. 2007;49:125\u201332.","journal-title":"Pediatr Int"},{"key":"1102_CR53","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1172\/JCI4165","volume":"103","author":"A Yachie","year":"1999","unstructured":"Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, Koizumi S. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest. 1999;103:129\u201335.","journal-title":"J Clin Invest"},{"key":"1102_CR54","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/74680","volume":"6","author":"LE Otterbein","year":"2000","unstructured":"Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, Davis RJ, Flavell RA, Choi AM. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med. 2000;6:422\u20138.","journal-title":"Nat Med"},{"key":"1102_CR55","doi-asserted-by":"publisher","first-page":"e42301","DOI":"10.1371\/journal.pone.0042301","volume":"7","author":"A Schumacher","year":"2012","unstructured":"Schumacher A, Wafula PO, Teles A, El-Mousleh T, Linzke N, Zenclussen ML, Langwisch S, Heinze K, Wollenberg I, Casalis PA, et al. Blockage of heme oxygenase-1 abrogates the protective effect of regulatory T cells on murine pregnancy and promotes the maturation of dendritic cells. PLoS One. 2012;7:e42301.","journal-title":"PLoS One"},{"key":"1102_CR56","doi-asserted-by":"publisher","first-page":"454","DOI":"10.2174\/138161208783597326","volume":"14","author":"ZW Xia","year":"2008","unstructured":"Xia ZW, Zhong WW, Meyrowitz JS, Zhang ZL. The role of heme oxygenase-1 in T cell-mediated immunity: the all encompassing enzyme. Curr Pharm Des. 2008;14:454\u201364.","journal-title":"Curr Pharm Des"},{"key":"1102_CR57","doi-asserted-by":"publisher","first-page":"5181","DOI":"10.4049\/jimmunol.174.9.5181","volume":"174","author":"TM Brusko","year":"2005","unstructured":"Brusko TM, Wasserfall CH, Agarwal A, Kapturczak MH, Atkinson MA. An integral role for heme oxygenase-1 and carbon monoxide in maintaining peripheral tolerance by CD4+CD25+ regulatory T cells. J Immunol. 2005;174:5181\u20136.","journal-title":"J Immunol"},{"key":"1102_CR58","doi-asserted-by":"publisher","first-page":"e00245","DOI":"10.1016\/j.heliyon.2017.e00245","volume":"3","author":"ML Gougeon","year":"2017","unstructured":"Gougeon ML, Poirier-Beaudouin B, Durant J, Lebrun-Frenay C, Saidi H, Seffer V, Ticchioni M, Chanalet S, Carsenti H, Harvey-Langton A, et al. HMGB1\/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Isorders (HAND). Heliyon. 2017;3:e00245.","journal-title":"Heliyon"},{"key":"1102_CR59","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/COH.0000000000000105","volume":"9","author":"MF Chen","year":"2014","unstructured":"Chen MF, Gill AJ, Kolson DL. Neuropathogenesis of HIV-associated neurocognitive disorders: roles for immune activation, HIV blipping and viral tropism. Curr Opin HIV AIDS. 2014;9:559\u201364.","journal-title":"Curr Opin HIV AIDS"},{"key":"1102_CR60","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/QAI.0000000000000532","volume":"69","author":"AM Anderson","year":"2015","unstructured":"Anderson AM, Harezlak J, Bharti A, Mi D, Taylor MJ, Daar ES, Schifitto G, Zhong J, Alger JR, Brown MS, et al. Plasma and cerebrospinal fluid biomarkers predict cerebral injury in HIV-infected individuals on stable combination antiretroviral therapy. J Acquir Immune Defic Syndr. 2015;69:29\u201335.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1102_CR61","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/infdis\/jiw506","volume":"215","author":"BM Imp","year":"2017","unstructured":"Imp BM, Rubin LH, Tien PC, Plankey MW, Golub ET, French AL, Valcour VG. Monocyte activation is associated with worse cognitive performance in HIV-infected women with virologic suppression. J Infect Dis. 2017;215:114\u201321.","journal-title":"J Infect Dis"},{"key":"1102_CR62","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ajpath.2017.08.035","volume":"188","author":"LM Mangus","year":"2018","unstructured":"Mangus LM, Beck SE, Queen SE, Brill SA, Shirk EN, Metcalf Pate KA, Muth DC, Adams RJ, Gama L, Clements JE, Mankowski JL. Lymphocyte-dominant encephalitis and meningitis in simian immunodeficiency virus-infected macaques receiving antiretroviral therapy. Am J Pathol. 2018;188:125\u201334.","journal-title":"Am J Pathol"},{"key":"1102_CR63","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/acn3.227","volume":"2","author":"OM Grauer","year":"2015","unstructured":"Grauer OM, Reichelt D, Gruneberg U, Lohmann H, Schneider-Hohendorf T, Schulte-Mecklenbeck A, Gross CC, Meuth SG, Wiendl H, Husstedt IW. Neurocognitive decline in HIV patients is associated with ongoing T-cell activation in the cerebrospinal fluid. Ann Clin Transl Neurol. 2015;2:906\u201319.","journal-title":"Ann Clin Transl Neurol"},{"key":"1102_CR64","doi-asserted-by":"crossref","unstructured":"Schrier RD, Hong S, Crescini M, Ellis R, Perez-Santiago J, Spina C, Letendre S, Group H: Cerebrospinal fluid (CSF) CD8+ T-cells that express interferon-gamma contribute to HIV associated neurocognitive disorders (HAND). PLoS One 2015, 10:e0116526.","DOI":"10.1371\/journal.pone.0116526"},{"key":"1102_CR65","doi-asserted-by":"crossref","unstructured":"Sanfilippo C, Pinzone MR, Cambria D, Longo A, Palumbo M, Di Marco R, Condorelli F, Nunnari G, Malaguarnera L, Di Rosa M. Mol Neurobiol; 2017. https:\/\/doi.org\/10.1007\/s12035-017-0460-3 . [Epub ahead of print]","DOI":"10.1007\/s12035-017-0460-3"},{"key":"1102_CR66","first-page":"106","volume":"23","author":"AM Anderson","year":"2017","unstructured":"Anderson AM, Lennox JL, Mulligan MM, Loring DW, Zetterberg H, Blennow K, Kessing C, Koneru R, Easley K, Tyor WR. Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-infected individuals. J Neuro-Oncol. 2017;23:106\u201312.","journal-title":"J Neuro-Oncol"},{"key":"1102_CR67","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.2174\/1389450111009011517","volume":"11","author":"A Jazwa","year":"2010","unstructured":"Jazwa A, Cuadrado A. Targeting heme oxygenase-1 for neuroprotection and neuroinflammation in neurodegenerative diseases. Curr Drug Targets. 2010;11:1517\u201331.","journal-title":"Curr Drug Targets"},{"key":"1102_CR68","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2174\/138161208783597399","volume":"14","author":"ML Ferrandiz","year":"2008","unstructured":"Ferrandiz ML, Devesa I. Inducers of heme oxygenase-1. Curr Pharm Des. 2008;14:473\u201386.","journal-title":"Curr Pharm Des"},{"key":"1102_CR69","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1089\/ars.2013.5658","volume":"20","author":"R Motterlini","year":"2014","unstructured":"Motterlini R, Foresti R. Heme oxygenase-1 as a target for drug discovery. Antioxid Redox Signal. 2014;20:1810\u201326.","journal-title":"Antioxid Redox Signal"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1102-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-018-1102-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1102-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T10:27:34Z","timestamp":1660559254000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-018-1102-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,6]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1102"],"URL":"https:\/\/doi.org\/10.1186\/s12974-018-1102-z","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,6]]},"assertion":[{"value":"5 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All NNTC studies were conducted in accordance with human subject protection protocols at participating institutions. Written informed consent was obtained for subjects at four collection sites in the USA. The following offices maintained the Institutional Review Boards that provided oversight for the protection of human subjects: (1) The University of Texas Medical Branch Office of Research Subject Protections; (2) Mount Sinai Medical Center Program for the Protection of Human Subjects; (3) University of California, San Diego Human Research Protections Program; and (4) University of California, Los Angeles Office of the Human Research Protection Program.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"70"}}